Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson’s Disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · see citing works

Parkinson's Disease

Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works

Parkinson disease

Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415 · see citing works

Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease

Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works

An Essay on the Shaking Palsy

Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,684 · see citing works

The novel object recognition memory: neurobiology, test procedure, and its modifications

Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390 · see citing works

The prevalence of Parkinson's disease: a systematic review and meta-analysis

Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188 · see citing works

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · see citing works

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · see citing works

Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein

Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., & Rubinsztein, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609532200 · Cited by 1,142 · see citing works

A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatinPreprint

Schotta, G., Lachner, M., Sarma, K., Ebert, A., Sengupta, R., Reuter, G., Reinberg, D., & Jenuwein, T. (2004) · Genes & Development · doi:10.1101/gad.300704 · Cited by 1,110 · see citing works

Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. ‐. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,087 · see citing works

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

Irwin, D. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3549 · Cited by 875 · see citing works

Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease

Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 777 · see citing works

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698 · see citing works

Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases

Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595 · see citing works

α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S.-I., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0098fje · Cited by 590 · see citing works

Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model

Chen, G., Ran, X., Li, B., Li, Y., He, D., Huang, B., Fu, S., Liu, J., & Wang, W. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.03.030 · Cited by 580 · see citing works

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Kontopoulos, E., Parvin, J. D., & Feany, M. Β. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 539 · see citing works

Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease

Kam, T.-I., Mao, X., Park, H., Chou, S.-C., Karuppagounder, S. S., Umanah, G. E., Yun, S. P., Brahmachari, S., Panicker, N., Chen, R., et al. (2018) · Science · doi:10.1126/science.aat8407 · Cited by 476 · see citing works

Assessment of Motor Balance and Coordination in Mice using the Balance Beam

Luong, T. N., Carlisle, H. J., Southwell, A. L., & Patterson, P. H. (2011) · Journal of Visualized Experiments · doi:10.3791/2376 · Cited by 401 · see citing works

Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy

Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D. S., & Stefanis, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005515 · Cited by 353 · see citing works

Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons

Castillo, K., Nassif, M., Valenzuela, V., Rojas, F., Matus, S., Mercado, G., Court, F. A., van Zundert, B., & Hetz, C. A. (2013) · Autophagy · doi:10.4161/auto.25188 · Cited by 338 · see citing works

The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy

Füllgrabe, J., Lynch-Day, M. A., Heldring, N., Li, W., Struijk, R. B., Ma, Q., Hermanson, O., Rosenfeld, M. G., Klionsky, D. J., & Joseph, B. (2013) · Nature · doi:10.1038/nature12313 · Cited by 328 · see citing works

Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis

DeBosch, B. J., Heitmeier, M. R., Mayer, A. L., Higgins, C. B., Crowley, J. R., Kraft, T. E., Chi, M., Newberry, E. P., Chen, Z., Finck, B. N., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aac5472 · Cited by 280 · see citing works

Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms

Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205 · see citing works

Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction

Lee, H.-J., Yoon, Y.-S., & Lee, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0749-9 · Cited by 194 · see citing works

Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson’s Disease: Involvement of α-Synuclein

Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M., & Contestabile, A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9090-5 · Cited by 172 · see citing works

Nitration and Inactivation of Tyrosine Hydroxylase by Peroxynitrite

Blanchard-Fillion, B., Souza, J. M., Friel, T., Jiang, G. C. ‐., Vrana, K. E., Sharov, V. S., Barrón, L., Schöneich, C., Quijano, C., Álvarez, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105564200 · Cited by 172 · see citing works

Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity

Sharma, S., Taliyan, R., & Singh, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.052 · Cited by 142 · see citing works

Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson’s Disease

He, Q., Koprich, J. B., Wang, Y., Yu, W., Xiao, B., Brotchie, J. M., & Wang, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9173-7 · Cited by 135 · see citing works

Cognitive impairment and BDNF serum levels

Siuda, J. S., Patalong‐Ogiewa, M., Żmuda, W., Targosz-Gajniak, M., Niewiadomska, E., Matuszek, I., Jędrzejowska–Szypułka, H., & Rudzińska, M. (2016) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2016.10.001 · Cited by 135 · see citing works

Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model

Sarkar, S., Chigurupati, S., Raymick, J. B., Mann, D., Bowyer, J. F., Schmitt, T., Beger, R. D., Hanig, J. P., Schmued, L. C., & Paule, M. G. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.07.006 · Cited by 128 · see citing works

The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells

Casarejos, M. J., Solano, R. M., Gómez, A., Perucho, J., de Yébenes, J. G., & Mena, M. A. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.008 · Cited by 114 · see citing works

Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis

Zhang, J., Yi, M., Zha, L., Chen, S., Li, Z., Li, C., Gong, M., Deng, H. X., Chu, X., Chen, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147218 · Cited by 100 · see citing works

Wnt/β‐catenin signalling induces MLL to create epigenetic changes in salivary gland tumours

Wend, P., Fang, L., Zhu, Q., Schipper, J. H., Loddenkemper, C., Kosel, F., Brinkmann, V., Eckert, K., Hindersin, S., Holland, J. D., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.127 · Cited by 95 · see citing works

Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease

Tanji, K., Miki, Y., Maruyama, A., Mimura, J., Matsumiya, T., Mori, F., Imaizumi, T., Itoh, K., & Wakabayashi, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.076 · Cited by 93 · see citing works

Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model

Qiao, C.-M., Sun, M., Jia, X.-B., Yang, L., Zhang, B.-P., Zhao, L., Shi, Y. W., Zhou, Z.-L., Zhu, Y., Cui, C., et al. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03074-3 · Cited by 92 · see citing works

Proteasome Inhibition Activates Autophagy-Lysosome Pathway Associated With TFEB Dephosphorylation and Nuclear Translocation

Li, C., Wang, X., Li, X., Qiu, K., Jiao, F., Liu, Y., Kong, Q., Liu, Y., & Wu, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00170 · Cited by 90 · see citing works

Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage

Béranger, F., Crozet, C., Goldsborough, A. S., & Lehmann, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.094 · Cited by 84 · see citing works

Behavioral Methods to Study Learning and Memory in Rats

Quillfeldt, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-11578-8_17 · Cited by 81 · see citing works

Localization of MAP1-LC3 in Vulnerable Neurons and Lewy Bodies in Brains of Patients With Dementia With Lewy Bodies

Higashi, S., Moore, D. J., Minegishi, M., Kasanuki, K., Fujishiro, H., Kabuta, T., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318211c86a · Cited by 61 · see citing works

Who was the man who discovered the “Lewy bodies”?

Silva, A. M. R. E., Geldsetzer, F. O., Holdorff, B., KIELHORN, F., Balzer‐Geldsetzer, M., Oertel, W. H., Hurtig, H. H., & Dodel, R. C. (2010) · Movement Disorders · doi:10.1002/mds.22956 · Cited by 58 · see citing works

Trehalose supplementation reduces hepatic endoplasmic reticulum stress and inflammatory signaling in old mice

Pagliassotti, M. J., Estrada, A. L., Hudson, W. M., Wei, Y., Wang, D., Seals, D. R., Zigler, M. L., & LaRocca, T. J. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.022 · Cited by 57 · see citing works

Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats

Sharma, S., & Deshmukh, R. R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.008 · Cited by 48 · see citing works

Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease

Bardag‐Gorce, F., Francis, T., Nan, L., Li, J., Lue, Y., French, B. A., & French, S. W. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.020 · Cited by 46 · see citing works

Supplementation of the diet of dairy cows with trehalose results in milk with low lipid peroxide and high antioxidant content

Aoki, N., Furukawa, S., Sato, K., Kurokawa, Y., KANDA, S., Takahashi, Y. K., Mitsuzumi, H., & Itabashi, H. (2010) · Journal of Dairy Science · doi:10.3168/jds.2009-2961 · Cited by 40 · see citing works

Exploring the Neuroprotective Potential of Rosiglitazone Embedded Nanocarrier System on Streptozotocin Induced Mice Model of Alzheimer’s Disease

Sarathlal, K. C., Kakoty, V., Marathe, S. A., Chitkara, D., & Taliyan, R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00258-1 · Cited by 39 · see citing works

Epigenetics in Parkinson’s and Alzheimer’s Diseases

Marques, S., & Outeiro, T. F. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_22 · Cited by 38 · see citing works

Autophagy Upregulation by the TFEB Inducer Trehalose Protects against Oxidative Damage and Cell Death Associated with NRF2 Inhibition in Human RPE Cells

Abokyi, S., Shan, S. W., To, C. H., Chan, H. H., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5296341 · Cited by 32 · see citing works

Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment

Ferguson, S. A., Law, C., & Sarkar, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.057 · Cited by 24 · see citing works

Biosynthesis of Astrocytic Trehalose Regulates Neuronal Arborization in Hippocampal Neurons

Martano, G., Gerosa, L., Prada, I., Garrone, G., Krogh, V., Verderio, C., & Passafaro, M. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00177 · Cited by 19 · see citing works

Time course of changes in antioxidant activity of milk from dairy cows fed a trehalose‐supplemented diet

Naoto, A. O. K. I., Sato, K., KANDA, S., Mukai, K., Obara, Y., & ITABASHI, H. (2012) · Animal Science Journal · doi:10.1111/j.1740-0929.2012.01040.x · Cited by 13 · see citing works

Trehalose induces SQSTM1/p62 expression and enhances lysosomal activity and antioxidative capacity in adipocytes

Kobayashi, M., Yasukawa, H., Arikawa, T., Deguchi, Y., Mizushima, N., Sakurai, M., Onishi, S., Tagawa, R., Sudo, Y., Okita, N., et al. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13055 · Cited by 13 · see citing works

The genetics of exploratory behavior

Crusio, W. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139541022.016 · Cited by 12 · see citing works

Ethogram of the mouse

Crusio, W. E., Sluyter, F., & Gerlai, R. T. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139541022.004 · Cited by 4 · see citing works

Pharmacological targeting of endoplasmic reticulum stress in disease

Marciniak, S. J., Chambers, J. E., & Ron, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 536 · see citing works

Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling

Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A. S., & Covașă, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 316 · see citing works

Disaccharide trehalose in experimental therapies for neurodegenerative disorders: Molecular targets and translational potential

Pupyshev, A. B., Klyushnik, T. P., Akopyan, A. A., Singh, S. K., & Tikhonova, M. A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106373 · Cited by 83 · see citing works

Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease

Guo, T.-T., Zhang, Z., Sun, Y., Zhu, R.-Y., Wang, F.-X., Ma, L.-J., Jiang, L., & Liu, H.-D. (2023) · Nutrients · doi:10.3390/nu15040930 · Cited by 82 · see citing works

Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic

Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 78 · see citing works

Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review

Mustapha, M., Ibrahim, N. M., Yap, K. H., Azmin, S., Makpol, S., Damanhuri, H. A., & Hamzah, J. C. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360164 · Cited by 32 · see citing works

Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation

Kakoty, V., Sarathlal, K. C., Kumari, S., Yang, C., Dubey, S. K., Sahebkar, A., Kesharwani, P., & Taliyan, R. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01187-z · Cited by 29 · see citing works

Buty and the beast: the complex role of butyrate in Parkinson’s disease

Elford, J. D., Becht, N. N., Garssen, J., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1388401 · Cited by 27 · see citing works

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works

Alpha Synuclein Toxicity and Non-Motor Parkinson’s

Mazzotta, G. M., & Conte, C. (2024) · Cells · doi:10.3390/cells13151265 · Cited by 19 · see citing works

Integrating nutriepigenomics in Parkinson’s disease management: New promising strategy in the omics era

Razali, K., Algantri, K., Loh, S. P., Cheng, S.-H., & Mohamed, W. M. Y. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.10.003 · Cited by 17 · see citing works

Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease

Kinet, R., & Dehay, B. (2023) · Cells · doi:10.3390/cells12040621 · Cited by 15 · see citing works

Neuroprotective Effect of Lentivirus-Mediated FGF21 Gene Delivery in Experimental Alzheimer’s Disease is Augmented when Concerted with Rapamycin

Kakoty, V., Sarathlal, K. C., Yang, C., Kumari, S., Dubey, S. K., & Taliyan, R. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02741-6 · Cited by 14 · see citing works

Treatment with sodium butyrate induces autophagy resulting in therapeutic benefits for spinocerebellar ataxia type 3

Watchon, M., Robinson, K. J., Luu, L., An, Y., Yuan, K. C., Plenderleith, S. K., Cheng, F., Don, E. K., Nicholson, G. A., Lee, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202300963rr · Cited by 15 · see citing works

Trehalose delays postmenopausal osteoporosis by enhancing AKT/TFEB pathway‑dependent autophagy flow in rats

Wang, Y., Li, X., Gao, H., & Lu, Q. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12237 · Cited by 10 · see citing works

Epigenetic regulation and autophagy modulation debilitates insulin resistance associated Alzheimer’s disease condition in rats

Kakoty, V., Sarathlal, K. C., Dubey, S. K., Yang, C., Marathe, S. A., & Taliyan, R. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00846-w · Cited by 10 · see citing works

Gut Microbiota Defined Epigenomes of Alzheimer’s and Parkinson’s Diseases Reveal Novel Targets for Therapy

Nohesara, S., Abdolmaleky, H. M., Thiagalingam, S., & Zhou, J. (2023) · Epigenomics · doi:10.2217/epi-2023-0342 · Cited by 17 · see citing works

Exploring the Epigenetic Regulated Modulation of Fibroblast Growth Factor 21 Involvement in High-Fat Diet Associated Parkinson’s Disease in Rats

Kakoty, V., Sarathlal, K. C., Yang, C., Dubey, S. K., & Taliyan, R. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00659 · Cited by 9 · see citing works

The role of gut-derived short-chain fatty acids in Parkinson's disease

Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 7 · see citing works

Spontaneous Object Exploration in a Recessive Gene Knockout Model of Parkinson’s Disease: Development and Progression of Object Recognition Memory Deficits in Male Pink1–/– Rats

Pinizzotto, C. C., Dreyer, K. M., Oluwagbohunmi, A., Caffrey, R. M., Madhira, K., & Kritzer, M. F. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.951268 · Cited by 7 · see citing works

Trehalose and Neurodegeneration: A Review of Its Role in Autophagy, Protein Aggregation, and Neuroprotection

Binas, S., Mardani, M., Siahtiri, S., & Nejad, A. M. (2025) · ASME Open Journal of Engineering · doi:10.1115/1.4068905 · Cited by 4 · see citing works

Exploration of the Therapeutic Potential of the Epigenetic Modulator Decitabine on 6-OHDA-Induced Experimental Models of Parkinson’s Disease

Kumari, S., Pradhan, R., Dubey, S. K., & Taliyan, R. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00875 · Cited by 3 · see citing works

Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson’s disease mouse model

Chen, R., Li, K., Wang, Y., Song, L., Wang, R., Fan, W., Zhao, N., Zou, W., Yang, Z., & Yan, J. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2315468 · Cited by 3 · see citing works

Associations of diet-derived short chain fatty acids with Parkinson’s disease: a systematic review and meta-analysis

An, K., Qu, Y., Li, J., Wang, D., Mao, Z., & Xue, Z. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2558119 · Cited by 2 · see citing works

Deciphering the modulatory role of short-chain fatty acids in Parkinson’s disease via phosphorylation-dependent signaling mechanisms

Liu, J., & Su, R. (2026) · PeerJ · doi:10.7717/peerj.20688 · Cited by 2 · see citing works

Trehalose as a potential therapeutic agent in different diseases

Stevanović, D., Trajković, V., & Vucicevic, L. M. (2023) · Medicinski podmladak · doi:10.5937/mp74-41378 · Cited by 1 · see citing works

Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis

Hosseini, L., Farshbaf‐Khalili, A., Jazani, A. M., & Maghsoumi‐Norouzabad, L. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04740-5 · Cited by 1 · see citing works

Computational Analysis of the Effect of Dietary Interventions on the Gut Microbiome Composition in Parkinson’s Disease

Franyer, L., Adrian, G. M., Oscar, B. A.-N., González, J., & Pinzón, A. M. (2025) · Bacteria · doi:10.3390/bacteria4040059 · Cited by 1 · see citing works

Examination of shared gut microbiome signatures in aging and Parkinson’s disease

Tng, T. J. W., Vanan, S., Tan, E.-K., Zeng, L., Goh, W. W. B., Wong, H. S., & Lim, K. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1745455 · Cited by 2 · see citing works

Nutrigenomics and Parkinson's disease

Razali, K., Algantri, K., Loh, S. P., Cheng, S.-H., & Mohamed, W. M. Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00035-x

Development and Validation of RP-HPLC Method for Simultaneous Determination of Decitabine and Repaglinide: Application to Solid Lipid Nanoparticle Formulations with In Vitro Neurotoxicity Assessment

Kumari, S., Gogikar, S. K., Dikundwar, A. G., Dubey, S. K., & Taliyan, R. (2025) · Chromatographia · doi:10.1007/s10337-025-04453-0

Rodent models for exploring the mechanisms contributing to Parkinson's disease pathophysiology

Allison, J., & Duty, S. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00003-8

Repurposing Anticancer Drugs in Parkinson’s Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement

Bedage, P. L., Dhanush, Y., Chettri, P., Shivakumar, Ahmed, S. S., & Raghunathanaidu, B. D. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06207-x

Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson’s Disease

He, Q., Koprich, J. B., Wang, Y., Yu, W., Xiao, B., Brotchie, J. M., & Wang, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9173-7 · Cited by 135 · see citing works

A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α-synuclein A30P + A53T transgenic mice

Ono, K., Ikemoto, M., Kawarabayashi, T., Ikeda, M., Nishinakagawa, T., Hosokawa, M., Shoji, M., Takahashi, M., & Nakashima, M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.03.002 · Cited by 85 · see citing works

Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils

Redmann, M., Wani, W. Y., Volpicelli-Daley, L., Darley-Usmar, V., & Zhang, J. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.032 · Cited by 46 · see citing works

Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells

Hu, G., Gong, X., Wang, L., Liu, M., Liu, Y., Fu, X., Wang, W., Zhang, T., & Wang, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9808-3 · Cited by 50 · see citing works

Metformin and Trehalose-Modulated Autophagy Exerts a Neurotherapeutic Effect on Parkinsonʼs Disease

Gopar‐Cuevas, Y., Cárdenas, O. S., Loera‐Arias, M. D. J., Montes‐de‐Oca‐Luna, R., Rodríguez‐Rocha, H., & García‐García, A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03530-5 · Cited by 38 · see citing works